Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teleflex

111.06
-2.5300-2.23%
Post-market: 111.770.7100+0.64%19:58 EDT
Volume:845.81K
Turnover:94.18M
Market Cap:4.91B
PE:34.72
High:114.36
Open:114.03
Low:110.83
Close:113.59
Loading ...

Teleflex Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
13 hours ago

Teleflex Announces Second Quarter 2025 Earnings Conference Call Information

GlobeNewswire
·
17 Jul

Teleflex Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
16 Jul

Morgan Stanley Remains a Buy on Teleflex (TFX)

TIPRANKS
·
16 Jul

Teleflex Is Maintained at Sector Perform by RBC Capital

Dow Jones
·
15 Jul

RBC Cuts Price Target on Teleflex to $130 From $145, Keeps Sector Perform Rating

MT Newswires Live
·
15 Jul

Teleflex Inc : RBC Cuts Target Price to $130 From $145

THOMSON REUTERS
·
15 Jul

Teleflex Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
12 Jul

Teleflex (TFX) Receives a Hold from Needham

TIPRANKS
·
08 Jul

Teleflex Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
08 Jul

Teleflex Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
04 Jul

Teleflex Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
02 Jul

Teleflex Completes Acquisition of BIOTRONIK’s Vascular Intervention Business, Expanding Global Presence

Reuters
·
01 Jul

Teleflex Completes Acquisition of Biotronik’s Vascular Intervention Business

THOMSON REUTERS
·
01 Jul

Teleflex - Amendment Provides Additional $200 Mln Delayed Draw Term Loan Commitments - SEC Filing

THOMSON REUTERS
·
30 Jun

Teleflex - on June 24, Enters Amendment to Third Amended and Restated Credit Agreement - SEC Filing

THOMSON REUTERS
·
30 Jun

Teleflex Inc. Secures $200 Million Additional Loan Commitments Through Credit Agreement Amendment to Fund Strategic Acquisition

Reuters
·
30 Jun

Teleflex Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
25 Jun

Teleflex Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
18 Jun

Teleflex Inc. Announces New Study Demonstrating 70.5% Reduction in Infection Rates with Arrow™ Chlorhexidine-Impregnated Central Venous Catheters

Reuters
·
12 Jun